Alerts will be sent to your verified email
Verify Email
HIKAL
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Hikal Limited provides a wide range of solutions in the life sciences value chain including manufacturing chemical intermediates, specialty chemicals, active pharma ingredients, and contract research services to global clients.
Hikal major competitors are Suven Life Sciences, Piramal Pharma, Suven Pharma, Sun Pharma Adv. Res, Dishman Carbogen Amc, Zenotech Laboratorie, Vivo Bio Tech.
Market Cap of Hikal is ₹5,142 Crs.
While the median market cap of its peers are ₹3,275 Crs.
Hikal seems to be less financially stable compared to its competitors.
Altman Z score of Hikal is 4.04 and is ranked 5 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | ||||||
| Investor Presentation | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Dec | Mar Jun Sep Dec | Jun | Mar Jun | Mar Jun Sep Dec | Mar Sep Dec | Mar Jun Dec | Jun Sep Dec | Sep Dec | |||||||
| Conference Call | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Mar Sep | Mar Sep | Mar Sep | |||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
